Breakthrough: FDA Greenlights Rapid Hepatitis C Test for Immediate Point-of-Care Diagnosis
Today, the U.S. Food and Drug Administration (FDA) granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert…
HCV Test
Read More
October 7, 2026
- Nobel Medicine 2026: From Light-Sensing Proteins to a Nobel-Winning Breakthrough
- China May Enter WHO Director-General Race With Late Nomination
- Russia Lab Worker’s Death Raises Questions Over Possible Plague Exposure and Biosecurity
- Haryana Plans Patient-Linked Incentives to Boost Public Hospital Utilisation